EUTM file information

018680634

SHORLA ONCOLOGY


March 30, 2022

Trademark Summary

The trademark application SHORLA ONCOLOGY was filed by Shorla Pharma Limited, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on April 19, 2022, and it was registered by office on July 27, 2022 without any oppositions.

The application was filed in English (French was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical and medicinal drugs, products, preparations and substances
    2. Pharmaceutical and medicinal preparations and substances for use in oncology
    3. Pharmaceutical preparations, products and substances for human use
    4. Pharmaceutical preparations, products and substances for the prevention and treatment of cancer
    5. Compounds for treating cancer
    6. Biological preparations for the treatment of cancer
    7. Pharmaceutical preparations, products and substances for the prevention of tumours
    8. Anti-cancer drugs and preparations.
  • The mark was filed in class 42 with following description of goods:
    1. Research and development services
    2. Biological research
    3. Scientific research services
    4. Research and development services in the pharmaceutical and biotechnology fields
    5. Research services relating to the development and testing of pharmaceutical preparations and medicines
    6. Pharmaceutical drug development services
    7. Pharmaceutical product evaluation
    8. Testing and inspection of pharmaceutical preparations and medicines
    9. Conducting clinical trials for pharmaceutical products
    10. Product safety and quality testing in the pharmaceutical and biotechnology fields
    11. Provision of information and data relating to research and development in the pharmaceutical and biotechnology fields.
Trademarkers